Skip to main content
DCGO
NASDAQ Industrial Applications And Services

DocGo to Acquire Hicuity Health for Stock and Debt Assumption, Secures $50M Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.68
Mkt Cap
$70.143M
52W Low
$0.451
52W High
$1.73
52W Position info
51% above low
Off High info
61% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

DCGO sits 51% above its 52-week low of $0.451.

Summary

DocGo is acquiring Hicuity Health for stock and debt assumption, securing up to $50M in new financing. The deal adds virtual care capabilities but increases leverage amid ongoing losses and Nasdaq compliance issues.


Key Events · M&A and Partnerships · DCGO

  • Definitive Merger Agreement Signed

    DocGo will acquire Hicuity Health via merger, with consideration of 2.0% of DocGo's fully diluted shares at closing plus an earnout of 3.5% tied to achieving a $250 million market cap within three years.

  • Debt Assumption and New Financing

    DocGo assumes approximately $52 million of Hicuity's existing debt maturing December 2029, and Perceptive Advisors committed up to $50 million in new senior secured term loans.

  • Q2 2026 Financial Results

    Revenue was $73.4 million, down from $80.4 million a year ago, with net loss of $18.0 million and adjusted EBITDA of -$6.3 million.

  • Lowered Full-Year Guidance

    2026 revenue guidance narrowed to $305-$310 million, and adjusted EBITDA guidance lowered to -$17 million to -$22 million, from prior -$5 million to -$10 million.


Analysis · DCGO · Industrial Applications And Services

DocGo signed a definitive agreement to acquire Hicuity Health, a virtual care provider, in a stock-and-debt deal. The merger consideration is 2.0% of DocGo's outstanding shares at closing plus an earnout of 3.5% tied to a $250 million market cap threshold. DocGo also assumes approximately $52 million of Hicuity's existing debt and has a commitment for up to $50 million in new term loans from Perceptive Advisors. The acquisition expands DocGo's telehealth capabilities but adds significant leverage at a time when the company is already facing Nasdaq delisting concerns and liquidity pressures. Q2 results showed continued losses, with adjusted EBITDA of -$6.3 million, and full-year guidance was lowered.

At the time of this filing, DCGO was trading at $0.68 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $70.1M. The 52-week trading range was $0.45 to $1.73. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DCGO - Latest Insights

DCGO
Aug 17, 2026, 4:22 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
DCGO
Jul 31, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
DCGO
Jul 03, 2026, 12:30 PM EDT
Source: PR Newswire
Importance Score:
7
DCGO
Jul 02, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
DCGO
Jul 02, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7